Tano, Jejie Rose .
HRN: 13-96-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2023
CEFUROXIME 500MG (TAB)
09/24/2023
09/30/2023
PO
500mg
BID
SP RMLE WITH REPAIR
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes